ALLMedicine™ Restrictive Cardiomyopathy Center
Research & Reviews 221 results
https://doi.org/10.1007/s10741-021-10159-w 10.1016/j.amjcard.2019.09.039 10.2459/JCM.0000000000000794 10.1016/S0140-6736(11)60101-3 10.1161/01.CIR.0000146819.43235.A9 10.1056/NEJM199108013250501 10.1016/0002-9343(84)90881-7 10.1161/01.CIR.67.4.807 10.1161/01.CIR.83.2.523 10.1111/anec.12032 10.1136/thx.37.9.711 10.1378/chest.104.2.618 10.1016/0002-9149(85)90995-6 10.1016/0002-9149(85)90996-8 10.1161/01.CIR.63.6.1285 10.1080/13506129.2018.1449744 10.1016/j.amjcard.2020.07.034 10.1002/ana.24725 10.1161/CIRCULATIONAHA.104.489187 10.1007/BF02267725 10.1212/WNL.0000000000005994 10.1016/j.jash.2013.04.006 10.1186/s13256-020-02405-w 10.1016/S0735-1097(84)80436-2 10.1136/hrt.78.1.74 10.1002/ehf2.12308 10.1161/CIRCULATIONAHA.111.078915 10.1161/CIRCULATIONAHA.108.785014 10.1016/j.jacep.2020.04.019 10.1080/13506129.2019.1620724 10.1016/j.jacc.2018.10.079 10.1016/j.hrthm.2015.09.016 10.1111/pace.13992 10.1093/europace/euz314 10.1093/eurheartj/ehy555 10.1023/A:1009795330454 10.1016/j.jacep.2019.10.013 10.1161/CIRCULATIONAHA.107.697763 10.1080/13506129.2020.1810010 10.1136/hrt.74.5.541 10.2459/JCM.0000000000000188 10.1093/eurheartj/ehi040 10.1056/NEJM199211263272205 10.1016/j.jacc.2017.10.021 10.1093/qjmed/91.2.141 10.1161/CIR.0b013e318276ce9b 10.1016/j.hrthm.2007.10.016 10.1002/clc.20389 10.1093/eurheartj/ehp592 10.1111/jce.12123 10.1016/j.hrthm.2013.10.026 10.1002/ejhf.1039 10.1038/s41598-019-44912-x 10.1056/NEJMoa1805689 10.1093/europace/euaa094 10.1016/j.jacc.2013.02.046 10.1016/S0735-1097(97)00267-2 10.1111/jce.14180 10.1016/S0140-6736(96)07015-8 10.1093/eurheartj/ehs381 10.1007/s00392-019-01490-2 10.1007/s13539-010-0008-0 10.1007/s12170-013-0353-6 10.1016/j.jand.2012.03.012 10.1016/j.cardfail.2013.01.011 10.1089/jpm.2014.0192 10.1007/s00228-005-0941-6 10.1002/mds.26086 10.1161/01.CIR.65.4.819 10.1136/bjo.66.10.676 10.1016/0002-9343(91)90187-3 10.1002/hep.1840090504
Heart Failure Reviews; Kim MM, Kolseth CM et. al.
Sep 3rd, 2021 - Clinical heart failure, restrictive cardiomyopathy, and arrhythmias are hallmark features of amyloid cardiomyopathy. In contrast to the advancements in targeted therapies, there is a general lack of evidence-based practice guidelines for clinical ...
Echocardiography (Mount Kisco, N.Y.); Gibson GT, Majure DT et. al.
Jul 24th, 2021 - Eosinophilic myocarditis, a rare and under-recognized disease process, occurs due to cytotoxic inflammation of the endomyocardium that over time may lead to a restrictive cardiomyopathy. We report clinical, multimodality imaging, and pathologic fi...
American Journal of Medical Genetics. Part A; Rumping L, Wessels MW et. al.
Jul 14th, 2021 - Terminal osseous dysplasia with pigmentary defects (TODPD), also known as digitocutaneous dysplasia, is one of the X-linked filaminopathies caused by a variety of FLNA-variants. TODPD is characterized by skeletal defects, skin fibromata and dysmor...
Journal of Cardiac Surgery; McGoldrick MT, Etchill EW et. al.
Jul 14th, 2021 - The incidence of systemic amyloidosis is rising, and there is a concomitant rise in heart transplant for an indication of cardiac amyloidosis. We utilized the Organ Procurement and Transplantation Network (OPTN) database to retrospectively assess ...
PloS One; Goland S, Volodarsky I et. al.
Jul 10th, 2021 - Transthyretin cardiac amyloidosis (ATTR-CA) is an increasingly recognized cause of heart failure (HF) with preserved left ventricular ejection fraction (LVEF), typically presenting as restrictive cardiomyopathy. The potential co-existence of ATTR-...
News 9 results
Feb 22nd, 2021 - Two UK hospitals have collaborated to expand the donation after circulatory death (DCD) heart transplant programme to children. Doctors behind the scheme said the world-first paediatric heart transplant technique, previously only available to adul...
Feb 11th, 2015 - A patient with constrictive pericarditis will have enhanced ventricular interaction arising from the restraint imposed by a rigid, diseased pericardium. That’s crucial.
Jan 30th, 2014 - Action Points The risk of dying within 90 days of being placed on a heart transplant wait-list was 10 times greater for patients with the most risk factors compared with those with the fewest, suggesting a need for revising the current heart alloc...
Debabrata Bandyopadhyay, MBBS, MD, Gursimran S. Kochhar, MD et. al.
Dec 1st, 2013 - A 42-year-old woman is admitted to the hospital with worsening shortness of breath on exertion, poor exercise tolerance, leg edema, and swelling of the abdomen. Her symptoms have been getting worse over the last 4 months.
Mar 7th, 2012 - Key Points for Practice This case raises many interesting and important points regarding Churg-Strauss vasculitis, including the following: ANCAs are not found in more than 50% of patients with Churg-Strauss vasculitis. In 2005, a multicenter stud...